Ozempic and blood sugar control: what TikTok gets wrong

What did @sueamanda38 actually say?

Honestly? It's nearly impossible to tell. The transcript from this video is largely incoherent, cycling through fragments like "I used to disinfect the water" and "I don't have any food" without forming a coherent medical claim about Ozempic or blood sugar control. The hashtags promise a sugar-control demonstration, but the words don't deliver one.

The caption tags #azúcar (sugar), #control, and #demostracion, which suggests the creator intended to show something related to blood glucose management, possibly connected to Ozempic's mechanism. But no clear demonstration, instruction, or factual statement about GLP-1 medications actually appears in the transcript. What we have is a series of disconnected phrases that don't add up to a medical claim, or frankly, any claim at all. With 639,000 views, that gap between implied promise and actual content matters.

Does the science back this up?

There is nothing specific enough in this transcript to fact-check against clinical evidence. That said, since the video is framed around Ozempic and blood sugar, it's worth covering what the actual science says on that topic, because the audience watching this presumably wants that information.

Semaglutide, the active ingredient in Ozempic, is a GLP-1 receptor agonist approved by the FDA for type 2 diabetes management. The SUSTAIN-6 trial (Marso et al., 2016, NEJM) showed significant HbA1c reductions alongside cardiovascular benefits in patients with type 2 diabetes. More recently, the SELECT trial (Lincoff et al., 2023, NEJM) demonstrated cardiovascular event reduction in people with obesity without diabetes. The glucose-lowering effect works primarily by stimulating insulin secretion in a glucose-dependent manner and suppressing glucagon, so it carries a low hypoglycemia risk when used without sulfonylureas. These are the actual facts about semaglutide and sugar control. None of them appear in this video.

What did they get wrong (or right)?

This one is genuinely difficult to score because no extractable factual claim was made. The creator gets no credit for accuracy, but also can't be penalized for spreading specific misinformation, because no specific information was shared. The misleading element here is structural, not factual.

The video uses Ozempic's name, a high-interest health hashtag, and the promise of a sugar-control demonstration to attract nearly 640,000 views, without actually informing any of those viewers. That's a problem. People searching for guidance on GLP-1 medications, blood sugar monitoring, or diabetes management are landing on content that gives them nothing clinically useful. That's not a neutral outcome. Algorithmically, this video competes for attention with content that might actually help someone understand whether semaglutide is right for them, or how to interpret their glucose readings. The water references could potentially relate to hydration practices while on GLP-1 therapy, a legitimate topic given that nausea and reduced intake are common side effects, but no coherent point is made.

What should you actually know?

If you found this video while researching Ozempic and blood sugar, here is what the evidence actually supports. Semaglutide does meaningfully reduce fasting and post-meal glucose levels in people with type 2 diabetes. It is not approved as a standalone treatment for blood sugar control in people without diabetes, though off-label interest exists.

A few things worth knowing if you're considering a GLP-1 medication:

• HbA1c reductions of 1.5 to 2 percentage points are typical in clinical trials for people with type 2 diabetes (Davies et al., 2021, Diabetes Care).
• Hydration matters. GLP-1 medications can reduce appetite and fluid intake, and some patients under-drink, which can cause issues, particularly with kidney function in vulnerable populations.
• Blood sugar "demonstrations" on social media, especially ones involving household water or food props, are not a substitute for glucose monitoring with a calibrated device.
• If you're using Ozempic for diabetes, your prescriber should be guiding your monitoring protocol, not a TikTok video.

Compounded semaglutide is not the same as Ozempic. The FDA has consistently flagged concerns about compounded GLP-1 products, and no compounded version has demonstrated equivalent safety or efficacy to the branded drug.